Arc 19Artificial Blood and Nano Pills
Wei Kang and Three Purities expanded Artificial Blood and Nano Pill trials, while Jian Lianyun and Kun City First People's Hospital gained recognition through medical collaboration with Cleveland Clinic. Three Purities’ growth continued, and Wei Kang invested System points in new medical technologies and potential treatments.
- Director Huang confirmed that the blood sample was Bombay type, and Liu Zhengming’s proposal to use Artificial Blood helped a badly injured patient receive a safe emergency transfusion.
- Wei Kang launched the electronic journal Life, and the Rare Blood Type Alliance partnered with Three Purities to produce affordable RH-negative blood as artificial blood began replacing the underground rare-blood trade.
- Wei Kang and Jian Lianyun completed astronaut training, traveled to the Space Station, and returned to Earth after Wei Kang’s spacewalk and their widely watched updates.
- Director Cui and Xue Kun treated two critically ill patients with Nano Pills, and their recoveries established the first human clinical trial’s success against severe infections.
- After learning about antibiotic resistance, Wei Kang established plans for an organic farm and research center, while Nano Pills helped Zhu Jun survive a nearly untreatable infection.
- Director Fang arranged a medical exchange with Cleveland Clinic, and Jian Lianyun successfully operated on a brainstem hemorrhage patient as the hospitals agreed to ongoing cooperation.
- Wei Kang reviewed Three Purities’ $78.2 billion annual revenue and used System points to obtain an Artificial Heart, other medical devices, and five potential drug treatments.